Skip to content
2000
Volume 8, Issue 1
  • ISSN: 1566-5232
  • E-ISSN: 1875-5631

Abstract

Baculovirus has emerged as a novel vector for in vivo and in vitro gene delivery. In addition, the applications of baculovirus-mediated gene transfer have been explosively expanded to drug screening, eucaryotic gene display, cancer therapy and tissue engineering, etc. The capability of baculovirus viral envelope for protein/peptide display also renders itself a potential vaccine delivery platform. This paper reviews the history, factors influencing baculovirus-mediated gene delivery and emerging in vitro, in vivo and ex vivo applications. Efforts aimed at overcoming current existing bottlenecks and recent progresses in addressing the safety concerns are particularly emphasized.

Loading

Article metrics loading...

/content/journals/cgt/10.2174/156652308783688509
2008-02-01
2026-02-19
Loading full text...

Full text loading...

/content/journals/cgt/10.2174/156652308783688509
Loading

  • Article Type:
    Research Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test